Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine for general anesthesia in cesarean section and impact on postpartum depression
ChiCTR2300078490Phase 4Not yet recruiting
- Sponsor
- The Fourth Hospital of Shijiazhuang
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postpartum depression (PPD) and postoperative pain (2 arms), sponsored by The Fourth Hospital of Shijiazhuang. Primary endpoint: Edinburgh Postnatal Depression Scale (EPDS) score. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
postpartum depression (PPD)postoperative pain
Beyond the preview
Go deeper on ChiCTR2300078490.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078490.